These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17062080)

  • 21. Excimer stamp test distinguishing between nevus depigmentosus and segmental vitiligo.
    Bae JM; Eun SH; Kim YH; Park JH; Hann SK
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):864-865. PubMed ID: 31365787
    [No Abstract]   [Full Text] [Related]  

  • 22. Dermoscopy of idiopathic guttate hypomelanosis.
    Errichetti E; Stinco G
    J Dermatol; 2015 Nov; 42(11):1118-9. PubMed ID: 26212033
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
    Dawid M; Veensalu M; Grassberger M; Wolff K
    J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field.
    Lommerts JE; Teulings HE; Ezzedine K; van Geel N; Hartmann A; Speeckaert R; Spuls PI; Wolkerstorfer A; Luiten RM; Bekkenk MW
    J Am Acad Dermatol; 2016 Dec; 75(6):1198-1204. PubMed ID: 27717621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nevus depigmentosus affecting the iris and skin: a case report.
    Sharma P; Pai HS; Kamath MM
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):634-5. PubMed ID: 18410630
    [No Abstract]   [Full Text] [Related]  

  • 26. Undifferentiated connective tissue disease with various pigmentary patterns: a study of three patients.
    Bukhari IA
    J Drugs Dermatol; 2004; 3(5):560-2. PubMed ID: 15552610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxically dark spontaneous repigmentation: a rare complication of generalized vitiligo.
    Agrawal S; Porto DA; Lim HW
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e268-e269. PubMed ID: 27785821
    [No Abstract]   [Full Text] [Related]  

  • 28. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo-like primary melanoma.
    Lugo-Somolinos A; Sánchez JL; Garcia ME
    Am J Dermatopathol; 2008 Oct; 30(5):451-4. PubMed ID: 18806487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo: Portrait of a woman with hypopigmented patches.
    Sevilla A
    Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):135. PubMed ID: 38031696
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematic review of occupational chemical leukoderma.
    Doolan BJ; Ross G
    Int J Dermatol; 2020 Mar; 59(3):e50-e52. PubMed ID: 31743421
    [No Abstract]   [Full Text] [Related]  

  • 32. Sudden eruption of pigmentary spots on vitiligo universalis patient: possible misdiagnosis.
    Han EC; Lee KY; Shin JU; Park YK; Roh MR
    Acta Derm Venereol; 2009; 89(2):192-3. PubMed ID: 19326013
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some functional tests of the skin in patients with vitiligo].
    Kapkaev RA; Uspenskaia ON
    Vestn Dermatol Venerol; 1966 Sep; 40(9):50-4. PubMed ID: 5998177
    [No Abstract]   [Full Text] [Related]  

  • 34. Idiopathic guttate hypomelanosis-like macules co-localizing to sites of topical photochemotherapy for vitiligo in children: Clinical and dermoscopic findings.
    Mehta N; Yadav D; Bhari N
    Indian J Dermatol Venereol Leprol; 2023; 89(2):301-303. PubMed ID: 36461798
    [No Abstract]   [Full Text] [Related]  

  • 35. What's your diagnosis? Loss of vulvar pigmentation in a two-year-old girl.
    Trager JD
    J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):121-4. PubMed ID: 15897110
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular basis of pigmentation disorders in skin diseases].
    Drukała J; Bobis S; Zabińska-Płazak E; Wojas-Pelc A
    Przegl Lek; 2009; 66(3):145-9. PubMed ID: 19689040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pigmentary disorders in Latin America.
    Falabella R
    Dermatol Clin; 2007 Jul; 25(3):419-30, x. PubMed ID: 17662907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics of vitiligo].
    Koshevenko IuN
    Vestn Dermatol Venerol; 1984 Mar; (3):60-3. PubMed ID: 6730672
    [No Abstract]   [Full Text] [Related]  

  • 39. Vitiligo and leukoderma in children.
    Herane MI
    Clin Dermatol; 2003; 21(4):283-95. PubMed ID: 14572699
    [No Abstract]   [Full Text] [Related]  

  • 40. The spectrophotometrical analysis of rhododendrol-induced leucoderma using a novel multispectral camera.
    Inoue M; Kikuchi K; Watabe A; Yamasaki K; Aiba S
    Br J Dermatol; 2016 Aug; 175(2):334-9. PubMed ID: 26991967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.